Navigation Links
VTT's vision of life in the era of a bioeconomy in Finland in 2044
Date:5/15/2014

tically in the future. Information technology will also play a more significant role in the future. It will become key in making manufacturing, energy production and transport more efficient.

"The transition to a bioeconomy requires us to learn how to use our natural resources in a wise and sparing manner. The efficient industrial use of biomass does not solve all the problems and other sources of raw material are also needed. One of them is the carbon dioxide in the atmosphere and combustion gas. However, we are still at the very early stages of this process", says Anne-Christine Ritschkoff, Executive Vice President of Strategic Research at VTT.

Helmi, the Anderson family and Jonas "Brad" Salmi in the era of a bioecenomy

The fictional characters of the VTT publication live in the era of a bioeconomy in 2044: Helmi lives in Taavetti in Eastern Finland with her family, the Anderson family live on the outskirts of the Helsinki metropolitan area, and international inventor Jonas "Brad" Salmi lives in Oulu.

Agriculture is booming in Finland because some of the traditional farming areas of the world have been destroyed as a result of various catastrophes. There is not enough work for everyone as robots are doing some of the work. Living conditions elsewhere in the world are deteriorating, and immigration to Finland is on the increase. Significant progress has been made in medical science and the onset of illnesses can be predicted based on the data on the individuals' vital functions. Medication is personalised. Sensors monitor the vital functions of individuals and send the data to doctors. People are still flying to their holiday destinations: bioenergy resources were introduced widely 20 years earlier and this has meant that the carbon footprint of air traffic is no longer an issue. Information technology is used to serve society in a variety of ways. 3D printing is an everyday thing. Food is almost entirely based on vegetables.

Once again, t
'/>"/>

Contact: Anne-Christine Ritschkoff
anne-christine.ritschkoff@vtt.fi
358-207-225-546
VTT Technical Research Centre of Finland
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Controlling brain waves to improve vision
2. Genome yields insights into golden eagle vision, smell
3. Cell division speed influences gene architecture
4. How vision makes sure that little fish do not get carried away
5. Cell division finding could boost understanding of cancer
6. Impaired cell division leads to neuronal disorder
7. Researchers identify key components linking circadian rhythms and cell division cycles
8. Hoyos Labs Receives Envisioneering Innovation & Design Award at the 2014 ShowStoppers at the Consumer Electronics Show
9. High-resolution 3-D imaging draws new picture of Golgis whereabouts during cell division
10. Scientists map food security and self-provision of major cities
11. SourceMedical Announces Hiring of Clinical Expert for ASC Division
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2015)... 2015 This report analyzes the worldwide markets for Face ... Biometrics, and Voice Biometrics. The report provides separate comprehensive analytics for ... , Europe , Asia-Pacific , ... , and Latin America . Annual estimates and ... seven-year historic analysis is provided for these markets. Market data and ...
(Date:2/13/2015)... 2015 ACT Genomics Co., Ltd., a ... transform cancer genomic information into precision diagnosis and ... raised US$ 8 million in the its first private ... Taipei, Taiwan , ACT Genomics has developed ... aim to implement next generation sequencing (NGS) and ...
(Date:2/9/2015)... RICHARDSON, Texas , Feb. 9, 2015  Lintec ... novel fabrication methods for carbon nanotube (CNT) macrostructures, including ... Texas at Dallas (UTD). Leveraging the vast ... Tokyo, Japan , Lintec of America ... Richardson, TX , focusing on scaling ...
Breaking Biology News(10 mins):World Face and Voice Biometrics Industry 2World Face and Voice Biometrics Industry 3World Face and Voice Biometrics Industry 4World Face and Voice Biometrics Industry 5World Face and Voice Biometrics Industry 6World Face and Voice Biometrics Industry 7World Face and Voice Biometrics Industry 8World Face and Voice Biometrics Industry 9World Face and Voice Biometrics Industry 10World Face and Voice Biometrics Industry 11World Face and Voice Biometrics Industry 12World Face and Voice Biometrics Industry 13World Face and Voice Biometrics Industry 14World Face and Voice Biometrics Industry 15World Face and Voice Biometrics Industry 16ACT Genomics Raises $8 Million in its First Private Funding Round 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4
... high blood pressure drugs may be useful in preventing and ... people with diabetes. The study, the largest to date on ... prevent or treat the sight-threatening disease, they say. The findings ... monthly publication. Edward Feener and colleagues point out ...
... Pneumonia A group led by Dr. James ... Human Infectious Diseases Research of The Methodist Hospital Research ... Paton-Valentine leukocidin (PVL) does not affect methicillin-resistant Staphlococcus ... can be found in the March 2010 issue of ...
... -- Oak Ridge National Laboratory researchers will lead projects ... processor hours of computing time on supercomputers located at ... awards were made through the U.S. Department of Energy ... Experiment (INCITE) program. This year, the INCITE program will ...
Cached Biology News:Tips from the American Journal of Pathology 2Tips from the American Journal of Pathology 3Tips from the American Journal of Pathology 4Tips from the American Journal of Pathology 52010 DOE INCITE projects allocated at ORNL 22010 DOE INCITE projects allocated at ORNL 32010 DOE INCITE projects allocated at ORNL 4
(Date:2/27/2015)... -- Bionomics Limited (ASX:BNO, ADR:BMICY) is to present important ... patients with metastatic renal cancer at the ASCO Genitourinary ... The data will be presented by Dr. Sumanta ... Center in California in his ... Ferritin and IL-8 as two baseline biomarkers that correlate ...
(Date:2/27/2015)... BOSTON , Feb. 27, 2015   PureTech ... identifying, inventing and commercializing disruptive products and technologies in ... Christopher Viehbacher , former CEO and Member of the ... Directors.  "It,s has been a pleasure ... very excited that we will be working together more ...
(Date:2/26/2015)... 2015   Synageva BioPharma Corp. (NASDAQ: ... therapeutic products for rare disorders, today reported 2014 ... other key objectives, and financial guidance.  Synageva,s management ... 4:30 p.m. EST to review the financial results ... in today,s call by telephone, please dial (877) ...
(Date:2/26/2015)... On behalf of biotech client GenScript ... Goldman & Spitzer, P.A. (Wilentz) secured a significant ... Inc. in excess of $10 million. The jury determined ... and that it improperly hired one or more of ... motions for judgment notwithstanding the verdict, a new trial, ...
Breaking Biology Technology:New BNC105 Biomarker Data to be Presented at US Cancer Conference 2New BNC105 Biomarker Data to be Presented at US Cancer Conference 3New BNC105 Biomarker Data to be Presented at US Cancer Conference 4New BNC105 Biomarker Data to be Presented at US Cancer Conference 5Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 2Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 3Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 4Synageva BioPharma Reports 2014 Full Year Financial Results 2Synageva BioPharma Reports 2014 Full Year Financial Results 3Synageva BioPharma Reports 2014 Full Year Financial Results 4Synageva BioPharma Reports 2014 Full Year Financial Results 5Synageva BioPharma Reports 2014 Full Year Financial Results 6Synageva BioPharma Reports 2014 Full Year Financial Results 7Synageva BioPharma Reports 2014 Full Year Financial Results 8Synageva BioPharma Reports 2014 Full Year Financial Results 9Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3
... Shire Limited,(LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical ... Annual General,Meeting on September 24, 2008, the Company has ... Shire plc,s ticker symbols on the London Stock ... Ordinary shares and American Depositary,Shares will remain unchanged., ...
... certification confirms implementation of quality systems in product ... ... cell function assay, COLUMBIA, Md., Oct. 1 ... 9001:2000. The 13485:2003 certification,includes compliance with the Canadian Medical ...
... ... Modern Medicines in Ukraine -, WASHINGTON, Sept. 30 ... Dr. Peter M. Leitner, President of,MaxWell USA, LLC, participated today ... (Logo: http://www.newscom.com/cgi-bin/prnh/20080624/NETU078LOGO ), The breakfast was hosted ...
Cached Biology Technology:Cylex(TM) Receives ISO 13485:2003 and 9001:2000 Quality Certifications 2Ukrainian President Yushchenko: Pharmaceuticals 'Very Important' 2
activating transcription factor 4 (tax-responsive enhancer element B67),...
The Hybrid Hunter Yeast Two-Hybrid System uses the activation of reporter genes to indicate positive protein-protein interactions. Two reporters are used an auxotrophic marker and lacZ....
Request Info...
Sprague Dawley rats, 7-8 weeks of age, mixed gender; collected by exsanguination in Alsever's solution at 1:2 dilution...
Biology Products: